General description
INN
Ravidasvir
Medicine type
Chemical agent
EML status history
First added in 2023
(TRS
1049)
for
Chronic hepatitis C
Wikipedia
DrugBank
Recommendations
Section
Medicines for hepatitis C > Pangenotypic direct-acting antiviral combinations
- Oral > Solid > tablet: 200 mg
Indications